CFD-ji (pogodbe za razliko) so kompleksni instrumenti in so zaradi uporabe finančnega vzvoda povezani z visokim tveganjem za hitro izgubo denarja. 84% vlagateljev izgubi denar, ko trguje s CFD-ji pri tem ponudniku. Razmisliti morate, ali razumete, kako delujejo CFD-ji in ali si lahko privoščite tako visoko tveganje za izgubo svojega denarja.
Capital Com Australia Pty Ltd Regulira ASIC Capital Com UK Limited Regulira Financial Conduct Authority (FCA) Capital Com SV Investments Limited Regulira CYSEC Сlosed Joint Stock Company «FinTech Solutions» Regulira NBRB Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Regulira FSA Capital Com Online Investments Ltd Regulira SCB Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Lahko nas kontaktirate tudi: pokličite +44 2030978888 support@capital.com

Trgovina Regeneron Pharmaceuticals, Inc. - REGN CFD

818.92
0.89%
1.04
Nizek: 818.92
Visok: 830.55
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Povzetek
  • Zgodovinski podatki
  • Dogodki
  • Izkaz poslovnega izida
  • Bilanca stanja
  • Denarni tok
  • Lastništvo
Pogoji trgovanja
Razmik 1.04
Nočna pristojbina za nakup

Long position overnight fee

Margin. Your investment $1,000.00
Nočna pristojbina -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Pojdi na platformo
-0.024068%
Nočna pristojbina za prodajo

Short position overnight fee

Margin. Your investment $1,000.00
Nočna pristojbina 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Pojdi na platformo
0.001846%
Čas nočne pristojbine 21:00 (UTC)
Min. tržena količina 1
Valuta USD
Kritje 20%
Borza United States of America
Provizija na trgovanje 0%

*Information provided by Capital.com

Regeneron Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

Ključni statistični podatki
Predhodno. Zapri* 826.3
Odpri* 830.55
Enoletna sprememba* 19.91%
Dnevni razpon* 818.92 - 830.55
Razpon 52 wk 538.01-832.48
Povprečni obseg (10 dni) 816.08K
Povprečni obseg (3 meseci) 13.25M
Tržna kapitalizacija 89.69B
Razmerje P/E 21.46
Število delnic v obtoku 109.33M
Prihodki 12.17B
EPS 38.24
Dividenda (donosnost v %) N/A
Beta 0.22
Datum naslednjega zaslužka May 2, 2023

Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Zapiranje Change Change (%) Odpiranje High Low
Mar 28, 2023 826.30 16.39 2.02% 809.91 826.85 809.91
Mar 27, 2023 819.49 -0.34 -0.04% 819.83 831.72 812.36
Mar 24, 2023 819.63 17.38 2.17% 802.25 823.61 795.78
Mar 23, 2023 801.72 -1.10 -0.14% 802.82 811.60 787.54
Mar 22, 2023 750.68 -8.68 -1.14% 759.36 764.03 750.15
Mar 21, 2023 758.90 0.41 0.05% 758.49 764.47 750.58
Mar 20, 2023 758.21 16.55 2.23% 741.66 759.65 741.65
Mar 17, 2023 747.35 1.81 0.24% 745.54 753.70 740.70
Mar 16, 2023 748.89 -2.86 -0.38% 751.75 752.05 725.56
Mar 15, 2023 759.88 7.50 1.00% 752.38 765.58 752.38
Mar 14, 2023 766.66 13.56 1.80% 753.10 769.29 753.01
Mar 13, 2023 752.05 6.55 0.88% 745.50 768.02 740.46
Mar 10, 2023 746.30 2.75 0.37% 743.55 758.66 736.92
Mar 9, 2023 743.15 -1.92 -0.26% 745.07 755.33 738.07
Mar 8, 2023 744.62 -27.39 -3.55% 772.01 772.76 743.57
Mar 7, 2023 773.11 -7.63 -0.98% 780.74 782.86 770.56
Mar 6, 2023 779.91 5.06 0.65% 774.85 785.00 768.08
Mar 3, 2023 778.57 13.47 1.76% 765.10 779.63 764.97
Mar 2, 2023 767.91 -0.13 -0.02% 768.04 772.37 760.64
Mar 1, 2023 769.69 15.12 2.00% 754.57 772.43 754.57

Regeneron Pharmaceuticals, Inc. Events

Čas (UTC) (UTC) Država Dogodek
No events scheduled
Oglejte si vse dogodke
  • Letni
  • Četrtletno
2022 2021 2020 2019 2018
Skupni prihodki 12172.9 16071.7 8497.1 7863.4 6710.8
Prihodki 12172.9 16071.7 8497.1 7863.4 6710.8
Celotni stroški prihodkov 1560.4 2437.5 1119.9 782.2 434.1
Bruto dobiček 10612.5 13634.2 7377.2 7081.2 6276.7
Celotni odhodki iz poslovanja 7434 7124.9 4920.5 5653.6 4176.4
Celotna prodaja/splošni/upravni stroški Odhodki 2115.9 1824.9 1346 1834.8 1556.2
Raziskave in razvoj 3592.5 2908.1 2735 3036.6 2186.1
Prihodki iz poslovanja 4738.9 8946.8 3576.6 2209.8 2534.4
Prihodki (odhodki) od obresti, neto Neoperativni -19.6 328.8 139.1 88.1 13.7
Drugo, neto 139.5 50.2 94.7 131.2 5.4
Čisti dobiček pred obdavčitvijo 4858.8 9325.8 3810.4 2429.1 2553.5
Čisti dobiček po davkih 4338.4 8075.3 3513.2 2115.8 2376.4
Čisti dobiček pred dodatnimi postavkami 4338.4 8075.3 3513.2 2115.8 2376.4
Čisti dobiček 4338.4 8075.3 3513.2 2115.8 2444.4
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk 4338.4 8075.3 3513.2 2115.8 2376.4
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami 4338.4 8075.3 3513.2 2115.8 2444.4
Prilagoditev za redčenje
Popravljen čisti dobiček 4338.4 8075.3 3513.2 2115.8 2444.4
Popravljene ponderirane povprečne delnice 113.5 112.2 115.1 114.6 114.8
Popravljen dobiček na delnico brez upoštevanja izrednih postavk 38.2238 71.9724 30.523 18.4625 20.7003
Dividends per Share - Common Stock Primary Issue
Popravljen normalizirani dobiček na enoto čistega dobička 40.4714 71.9724 30.523 18.4625 20.7003
Skupaj izredne postavke 68
Other Operating Expenses, Total -89.9 -45.6 -280.4
Nenavadni odhodki (prihodki) 255.1
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Skupni prihodki 3414.4 2936.2 2857.2 2965.1 4951.7
Prihodki 3414.4 2936.2 2857.2 2965.1 4951.7
Celotni stroški prihodkov 540.6 317.8 297.1 404.9 982.6
Bruto dobiček 2873.8 2618.4 2560.1 2560.2 3969.1
Celotni odhodki iz poslovanja 2267.6 1712.5 1747.3 1706.6 2312
Celotna prodaja/splošni/upravni stroški Odhodki 660.5 529.1 476.3 450 559.6
Raziskave in razvoj 1043.1 911.3 794.3 843.8 785.6
Other Operating Expenses, Total -6.6 -45.7 -17.4 -20.2 -15.8
Prihodki iz poslovanja 1146.8 1223.7 1109.9 1258.5 2639.7
Prihodki (odhodki) od obresti, neto Neoperativni 143 239 -176.8 -224.8 -151.8
Drugo, neto 34.9 47.1 30.1 27.4 15.5
Čisti dobiček pred obdavčitvijo 1324.7 1509.8 963.2 1061.1 2503.4
Čisti dobiček po davkih 1197.1 1315.7 852.1 973.5 2229
Čisti dobiček pred dodatnimi postavkami 1197.1 1315.7 852.1 973.5 2229
Čisti dobiček 1197.1 1315.7 852.1 973.5 2229
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk 1197.1 1315.7 852.1 973.5 2229
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami 1197.1 1315.7 852.1 973.5 2229
Popravljen čisti dobiček 1197.1 1315.7 852.1 973.5 2229
Popravljene ponderirane povprečne delnice 114.1 112.8 114 113.1 113.4
Popravljen dobiček na delnico brez upoštevanja izrednih postavk 10.4917 11.664 7.47456 8.60743 19.6561
Dividends per Share - Common Stock Primary Issue 0 0 0
Popravljen normalizirani dobiček na enoto čistega dobička 10.7546 11.664 9.20263 8.85588 19.6561
Nenavadni odhodki (prihodki) 30 0 197 28.1
  • Letni
  • Četrtletno
2021 2020 2019 2018 2017
Kratkoročna sredstva skupaj 14014.9 9779.1 7689.1 6447.6 4335.03
Denarna sredstva in kratkoročne naložbe 5694.7 3587 3214.3 2809.9 1409.58
Denarna sredstva in ustrezniki 2885.6 2193.7 1617.8 1467.7 812.733
Kratkoročne naložbe 2809.1 1393.3 1596.5 1342.2 596.847
Celotne terjatve, neto 6036.5 4114.7 2672.2 2243.2 1974.34
Accounts Receivable - Trade, Net 6036.5 4114.7 2672.2 2243.2 1974.34
Total Inventory 1502.8 1485.7 1014.6 822.3 513.878
Prepaid Expenses 332.4 160.8 387.1 243.3 224.972
Other Current Assets, Total 448.5 430.9 400.9 328.9 212.26
Total Assets 25434.8 17163.3 14805.2 11734.5 8764.29
Property/Plant/Equipment, Total - Net 3482.2 3221.6 2890.4 2575.8 2358.6
Property/Plant/Equipment, Total - Gross 4880.3 4352.7 3812.8 3304.5 2924.9
Accumulated Depreciation, Total -1398.1 -1131.1 -922.4 -728.7 -566.294
Long Term Investments 6878 3194.8 3312.4 1800.5 1486.49
Other Long Term Assets, Total 1059.7 967.8 913.3 910.6 584.157
Total Current Liabilities 3932.5 2697.4 2096.6 1442.8 1135.48
Accounts Payable 564 475.5 418.1 218.2 178.183
Accrued Expenses 1880.5 1502.3 1037.4 751.3 636.668
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 719.7 0
Other Current Liabilities, Total 768.3 719.6 641.1 473.3 320.632
Total Liabilities 6666 6138 3715.5 2977.2 2620.21
Total Long Term Debt 1980 2695.7 713.9 708.5 703.453
Capital Lease Obligations 0 717.2 713.9 708.5 703.453
Other Liabilities, Total 753.5 744.9 905 825.9 781.272
Total Equity 18768.8 11025.3 11089.7 8757.3 6144.08
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.1 0.1 0.1 0.1 0.112
Additional Paid-In Capital 8087.5 6716.2 4428.6 3911.6 3512.83
Retained Earnings (Accumulated Deficit) 18968.3 10893 7379.8 5254.3 2946.73
Treasury Stock - Common -8260.9 -6613.3 -739.9 -396.4 -316.24
Other Equity, Total -26.2 29.3 21.1 -12.3 0.64
Total Liabilities & Shareholders’ Equity 25434.8 17163.3 14805.2 11734.5 8764.29
Total Common Shares Outstanding 108.675 106.951 110.277 109.006 107.625
Long Term Debt 1980 1978.5
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Kratkoročna sredstva skupaj 14306 14014.9 13775.4 13337.6 10055.1
Denarna sredstva in kratkoročne naložbe 7050.6 5694.7 5787.6 3910.8 3503.8
Denarna sredstva in ustrezniki 3345.7 2885.6 3432.4 2072.2 1437.9
Kratkoročne naložbe 3704.9 2809.1 2355.2 1838.6 2065.9
Celotne terjatve, neto 4839 6036.5 5452 6998.6 4173
Accounts Receivable - Trade, Net 4839 6036.5 5452 6998.6 4173
Total Inventory 1465.7 1502.8 1550.1 1448.9 1665.3
Prepaid Expenses 424.9 332.4 482 444.3 213.6
Other Current Assets, Total 525.8 448.5 503.7 535 499.4
Total Assets 26348.7 25434.8 23671.5 21485.9 17772.2
Property/Plant/Equipment, Total - Net 3556.4 3482.2 3395.7 3358.5 3262.6
Long Term Investments 7130.7 6878 5671.3 3940.3 3583.7
Other Long Term Assets, Total 1355.6 1059.7 829.1 849.5 870.8
Total Current Liabilities 3007.6 3932.5 3714.8 3732.4 3217.8
Accounts Payable 470.3 564 427 476 542.9
Accrued Expenses 2046 2206.8 2061 2018 1492.2
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 719.7 719 718.4 717.8
Other Current Liabilities, Total 491.3 442 507.8 520 464.9
Total Liabilities 6434 6666 6413.5 6358.6 5795.2
Total Long Term Debt 2700.4 1980 1979.6 1979.2 1978.9
Long Term Debt 1980.4 1980 1979.6 1979.2 1978.9
Capital Lease Obligations 720 0 0 0 0
Other Liabilities, Total 726 753.5 719.1 647 598.5
Total Equity 19914.7 18768.8 17258 15127.3 11977
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.1 0.1 0.1 0.1 0.1
Additional Paid-In Capital 8754.1 8087.5 7919.3 7225.8 6887.8
Retained Earnings (Accumulated Deficit) 19941.8 18968.3 16739.3 15107.1 12008.2
Treasury Stock - Common -8611.2 -8260.9 -7410.2 -7221.4 -6935.3
Other Equity, Total -170.1 -26.2 9.5 15.7 16.2
Total Liabilities & Shareholders’ Equity 26348.7 25434.8 23671.5 21485.9 17772.2
Total Common Shares Outstanding 109.507 108.675 108.527 106.72 106.644
  • Letni
  • Četrtletno
2021 2020 2019 2018 2017
Čisti prihodki/začetna postavka 8075.3 3513.2 2115.8 2444.4 1198.51
Denarna sredstva iz poslovanja 7081.3 2618.1 2430 2195.1 1307.11
Denarna sredstva iz poslovanja 286.2 235.9 210.3 148.2 145.467
Deferred Taxes -147.1 75.6 -130.6 -140 318.809
Nedenarne postavke 783.4 297 435 439.5 570.858
Cash Taxes Paid 1218.4 188.1 342.3 205.6 754.843
Denarna sredstva Plačane obresti 55.8 23.2 25 22.3 18.678
Spremembe v obratnem kapitalu -1916.5 -1503.6 -200.5 -697 -926.533
Denarna sredstva pri naložbenju -5384.7 -70.6 -2027.8 -1463 -1005.18
Kapitalski izdatki -551.9 -614.6 -429.6 -383.1 -272.626
Celotne druge postavke denarnih tokov pri naložbenju -4832.8 544 -1598.2 -1079.9 -732.556
Denarna sredstva pri financiranju -1005.8 -1970.5 -252.1 -77.1 -24.4
Postavke denarnega toka pri financiranju -1032.7 -680.8 -188 -187.2 -301.688
Izdaja (odplačilo) delnic, neto 26.9 -3271.6 -64.1 110.1 240.213
Izdaja (odplačilo) dolga, neto 0 1981.9 0 37.075
Neto sprememba denarnih sredstev 690.8 577 150.1 655 277.53
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 973.5 8075.3 5846.3 4214.1 1115.2
Cash From Operating Activities 2101.7 7081.3 4708.8 1295.2 668.5
Cash From Operating Activities 74.3 286.2 211.7 138.5 67.4
Deferred Taxes -225 -147.1 58.8 51.8 10.1
Non-Cash Items 455.7 783.4 153.1 -84.9 15.2
Changes in Working Capital 823.2 -1916.5 -1561.1 -3024.3 -539.4
Cash From Investing Activities -1705.3 -5384.7 -3372 -933.2 -1059
Capital Expenditures -141.8 -551.9 -397 -263.8 -115.3
Other Investing Cash Flow Items, Total -1563.5 -4832.8 -2975 -669.4 -943.7
Cash From Financing Activities 64.7 -1005.8 -99.2 -484.6 -366.4
Financing Cash Flow Items -98.8 -1032.7 -450.3 -180.7 -154.5
Issuance (Retirement) of Stock, Net 163.5 26.9 351.1 -303.9 -211.9
Net Change in Cash 461.1 690.8 1237.6 -122.6 -756.9
Issuance (Retirement) of Debt, Net 0 0 0
Ime vlagatelja Vrsta vlagatelja Odstotek neporavnanih obveznosti Delnice v lasti Sprememba delnic Datum imetništva Ocena prometa
Fidelity Management & Research Company LLC Investment Advisor 9.914 10658247 268103 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.0656 8671077 74457 2022-12-31 LOW
Capital World Investors Investment Advisor 5.8065 6242435 16836 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.7272 6157131 -211997 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.6145 4960885 -90874 2022-12-31 LOW
JP Morgan Asset Management Investment Advisor 4.4213 4753254 301869 2022-12-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.2475 2416247 -27042 2022-12-31 LOW
Dodge & Cox Investment Advisor/Hedge Fund 2.0678 2223059 -63450 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0538 2207990 -32123 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 1.4723 1582798 -28736 2022-12-31 LOW
Capital International Investors Investment Advisor 1.4231 1529943 -237193 2022-12-31 LOW
Invesco Capital Management (QQQ Trust) Investment Advisor 1.2962 1393537 7205 2023-02-28 LOW
Loomis, Sayles & Company, L.P. Investment Advisor/Hedge Fund 1.2443 1337681 -378936 2022-12-31 LOW
Yancopoulos (George D) Individual Investor 1.1527 1239194 -79973 2022-04-12 LOW
Putnam Investment Management, L.L.C. Investment Advisor/Hedge Fund 1.0395 1117533 13700 2022-12-31 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.025 1102002 -76069 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.899 966467 1776 2022-12-31 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.7992 859202 -22201 2022-12-31 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7733 831369 -41616 2022-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7213 775449 -12042 2022-12-31 LOW

Zakaj izbrati Capital.com? Številke govorijo same zase.

Capital.com Group

500K+

Borzni posredniki

92K+

Aktivne stranke mesečno

$53M+

Mesečni obseg naložb

$30M+

Dvigi vsak mesec

Kalkulator trgovanja

Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).

Trgovalna provizija
0
  • 1:1
Vzvod
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje

Zapiranje

Kratka Dolga
Pretekla uspešnost ni zanesljiv pokazatelj prihodnjih rezultatov.
Dobiček/Izguba

Regeneron Company profile

O družbi Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. je integrirano biotehnološko podjetje, ki odkriva, izumlja, razvija, proizvaja in trži zdravila za hude bolezni. Komercializirana zdravila in izdelki v razvoju so namenjeni bolnikom z očesnimi boleznimi, alergijskimi in vnetnimi boleznimi, rakom, srčno-žilnimi in presnovnimi boleznimi, bolečinami, hematološkimi boleznimi, nalezljivimi boleznimi in redkimi boleznimi. Trženi izdelki družbe vključujejo zdravila EYLEA (aflibercept) injekcija, Dupixent (dupilumab) injekcija, Libtayo (cemiplimab) injekcija, Praluent (alirokumab) injekcija, REGEN-COV, Kevzara (sarilumab) raztopina za podkožno injiciranje, Evkeeza (evinakumab) injekcija, Inmazeb (atoltivimab, maftivimab in odesivimab-ebgn) injekcija, ARCALYST (rilonacept) injekcija za podkožno uporabo in ZALTRAP (ziv-aflibercept) injekcija za intravensko infuzijo. Njegovi izdelki v kliničnem razvoju so med drugim REGN4018, REGN5668 in Fasinumab.

Industry: Bio Therapeutic Drugs

777 Old Saw Mill River Road
TARRYTOWN
NEW YORK 10591
US

Izkaz poslovnega izida

  • Annual
  • Quarterly

Ljudje gledajo tudi

BTC/USD

28,332.05 Price
+3.790% 1D Chg, %
Nočna pristojbina za nakup -0.0616%
Nočna pristojbina za prodajo 0.0137%
Čas nočne pristojbine 21:00 (UTC)
Razmik 60.00

Oil - Crude

72.93 Price
-0.830% 1D Chg, %
Nočna pristojbina za nakup -0.0162%
Nočna pristojbina za prodajo -0.0057%
Čas nočne pristojbine 21:00 (UTC)
Razmik 0.03

US100

12,817.30 Price
+1.530% 1D Chg, %
Nočna pristojbina za nakup -0.0241%
Nočna pristojbina za prodajo 0.0018%
Čas nočne pristojbine 21:00 (UTC)
Razmik 1.8

Gold

1,958.65 Price
-0.660% 1D Chg, %
Nočna pristojbina za nakup -0.0087%
Nočna pristojbina za prodajo 0.0005%
Čas nočne pristojbine 21:00 (UTC)
Razmik 0.30

Še vedno iščete posrednika, ki mu lahko zaupate?

Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com

1. Ustvarite in preverite svoj račun 2. Naredite polog 3. Poiščite svoje trgovanje